Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,933 | 132 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $295.74 | 18 | $0 (2021) |
| Novo Nordisk Inc | $236.67 | 24 | $0 (2024) |
| Amgen Inc. | $222.67 | 13 | $0 (2021) |
| PFIZER INC. | $170.71 | 12 | $0 (2023) |
| Amarin Pharma Inc. | $168.06 | 10 | $0 (2021) |
| Lilly USA, LLC | $128.85 | 9 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $117.32 | 8 | $0 (2022) |
| Merck Sharp & Dohme Corporation | $101.56 | 7 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $96.27 | 7 | $0 (2020) |
| Novartis Pharmaceuticals Corporation | $95.28 | 6 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $35.18 | 2 | Novo Nordisk Inc ($35.18) |
| 2023 | $15.36 | 1 | PFIZER INC. ($15.36) |
| 2022 | $29.80 | 2 | PFIZER INC. ($16.37) |
| 2021 | $203.55 | 13 | Amarin Pharma Inc. ($57.09) |
| 2020 | $474.95 | 28 | AstraZeneca Pharmaceuticals LP ($179.00) |
| 2019 | $334.72 | 23 | Amgen Inc. ($56.25) |
| 2018 | $433.06 | 36 | Novo Nordisk Inc ($115.62) |
| 2017 | $405.99 | 27 | Lilly USA, LLC ($68.69) |
All Payment Transactions
132 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Diabetes | ||||||
| 01/31/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $18.85 | General |
| Category: Diabetes | ||||||
| 03/13/2023 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.36 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/27/2022 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/23/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug), JARDIANCE | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: DIABETES | ||||||
| 12/06/2021 | AbbVie Inc. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: NEUROSCIENCE | ||||||
| 09/29/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Cardiovascular | ||||||
| 09/21/2021 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $12.40 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2021 | DEXCOM, INC. | DEXCOM G6 TRANSMITTER (Device) | Food and Beverage | In-kind items and services | $26.14 | General |
| Category: ENDOCRINOLOGY | ||||||
| 04/29/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $11.13 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 03/16/2021 | PFIZER INC. | COLOGUARD DNA CAPTURE REAGENTS (Device), REYVOW | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: GASTROINTESTINAL | ||||||
| 03/10/2021 | PFIZER INC. | ELIQUIS (Drug), COLOGUARD DNA CAPTURE REAGENTS | Food and Beverage | In-kind items and services | $17.23 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 02/17/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $18.68 | General |
| Category: Cardiovascular | ||||||
| 02/04/2021 | SANOFI-AVENTIS U.S. LLC | SOLIQUA 100/33 (Biological) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 01/29/2021 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $12.43 | General |
| Category: Diabetes | ||||||
| 01/26/2021 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.25 | General |
| Category: Respiratory | ||||||
| 01/20/2021 | Amgen Inc. | Aimovig (Biological), Otezla, Repatha | Food and Beverage | In-kind items and services | $14.30 | General |
| Category: Neuroscience | ||||||
| 01/12/2021 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Cardiovascular | ||||||
| 12/09/2020 | Amarin Pharma Inc. | Vascepa (Drug) | Food and Beverage | In-kind items and services | $21.54 | General |
| Category: Cardiovascular | ||||||
| 11/16/2020 | AstraZeneca Pharmaceuticals LP | BREZTRI AEROSPHERE (Drug) | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: Respiratory | ||||||
| 11/12/2020 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: Inflammation | ||||||
| 11/11/2020 | Novo Nordisk Inc | Ozempic (Drug), RYBELSUS | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Diabetes | ||||||
| 10/16/2020 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $15.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/07/2020 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 09/29/2020 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 110 | 186 | $39,297 | $12,679 |
| 2021 | 15 | 449 | 641 | $123,723 | $35,718 |
| 2020 | 21 | 1,058 | 2,107 | $313,467 | $143,191 |
All Medicare Procedures & Services
40 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 48 | 114 | $20,406 | $6,916 | 33.9% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 26 | 28 | $9,268 | $2,700 | 29.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 23 | 25 | $4,775 | $1,534 | 32.1% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 13 | 19 | $4,848 | $1,528 | 31.5% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 100 | 240 | $42,960 | $12,940 | 30.1% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 64 | 67 | $11,993 | $3,690 | 30.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 25 | 42 | $10,703 | $3,126 | 29.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 19 | 20 | $9,864 | $2,917 | 29.6% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 24 | 24 | $8,004 | $2,415 | 30.2% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 29 | 41 | $6,929 | $2,168 | 31.3% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 23 | 33 | $5,940 | $1,709 | 28.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 52 | 59 | $6,785 | $1,457 | 21.5% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 14 | 14 | $4,608 | $1,303 | 28.3% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 12 | 12 | $5,406 | $1,297 | 24.0% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 19 | 19 | $3,401 | $977.87 | 28.8% |
| 99221 | Initial hospital inpatient care, typically 30 minutes per day | Facility | 2021 | 12 | 12 | $2,972 | $947.64 | 31.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 24 | 26 | $2,158 | $458.63 | 21.3% |
| 93016 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring and physician supervision | Facility | 2021 | 16 | 16 | $1,200 | $175.78 | 14.6% |
| 93018 | Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician interpretation and report | Facility | 2021 | 16 | 16 | $800.00 | $135.77 | 17.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 315 | 804 | $92,165 | $56,319 | 61.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 227 | 459 | $38,097 | $21,683 | 56.9% |
| 99236 | Hospital observation or inpatient care high severity, 55 minutes per day | Facility | 2020 | 21 | 68 | $20,199 | $11,790 | 58.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 80 | 200 | $35,832 | $11,550 | 32.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 71 | 77 | $38,597 | $11,537 | 29.9% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2020 | 29 | 30 | $6,908 | $5,433 | 78.7% |
About Dr. Bruce Leslie, M.D
Dr. Bruce Leslie, M.D is a Internal Medicine healthcare provider based in Petersburg, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/13/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457455958.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bruce Leslie, M.D has received a total of $1,933 in payments from pharmaceutical and medical device companies, with $35.18 received in 2024. These payments were reported across 132 transactions from 24 companies. The most common payment nature is "Food and Beverage" ($1,933).
As a Medicare-enrolled provider, Leslie has provided services to 1,617 Medicare beneficiaries, totaling 2,934 services with total Medicare billing of $191,588. Data is available for 3 years (2020–2023), covering 40 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Petersburg, WV
- Active Since 09/13/2006
- Last Updated 03/11/2010
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1457455958
Products in Payments
- Vascepa (Drug) $168.06
- Ozempic (Drug) $154.51
- SYMBICORT (Drug) $141.23
- Aimovig (Biological) $113.45
- FARXIGA (Drug) $112.47
- TRADJENTA (Drug) $112.12
- ENTRESTO (Drug) $95.28
- CHANTIX (Drug) $82.35
- JANUVIA (Drug) $76.62
- ELIQUIS (Drug) $73.69
- INVOKANA (Drug) $70.42
- Repatha (Biological) $64.89
- TRULICITY (Drug) $46.26
- EMGALITY (Drug) $45.97
- TROKENDI XR (Drug) $43.89
- Prolia (Biological) $29.18
- DEXCOM G6 TRANSMITTER (Device) $26.14
- JARDIANCE (Drug) $25.95
- XARELTO (Drug) $25.85
- SOLIQUA 100/33 (Biological) $23.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Petersburg
Sajid Naveed, Md, MD
Internal Medicine — Payments: $9,344
Nishanth Sukumaran, Md, MD
Internal Medicine — Payments: $6,306
Raphael Agada, Md, MD
Internal Medicine — Payments: $5,908
Dr. Lerla Joseph, M.d, M.D
Internal Medicine — Payments: $5,815
Dr. Stephen Thompson, D.o, D.O
Internal Medicine — Payments: $5,205
Benjamin Leslie, D.o, D.O
Internal Medicine — Payments: $4,891